Speziale P, Höök M, Switalski L M, Wadström T
J Bacteriol. 1984 Feb;157(2):420-7. doi: 10.1128/jb.157.2.420-427.1984.
In previous studies, Staphylococcus aureus has been shown to bind fibronectin (P. Kuusela, Nature (London) 276:718-720, 1978), an interaction that may be important in bacterial attachment and opsonization. Recently some strains of streptococci of serological groups A, C, and G were also found to bind fibronectin. The binding to one selected strain of Streptococcus pyogenes has been characterized here. The binding of [125I]fibronectin to streptococcal cells resembles that to staphylococcal cells and was found to be time dependent, functionally irreversible, and specific in the sense that unlabeled proteins other than fibronectin did not block binding. Bacteria incubated with proteases largely lost their ability to bind fibronectin, and material released from the streptococci by a brief trypsin digestion contained active fibronectin receptors. This material inhibited the binding of [125I]fibronectin to the streptococci. The inhibitory activity was adsorbed on a column of fibronectin-Sepharose but not on a column of unsubstituted Sepharose 4B or egg albumin Sepharose. The receptor appeared to be a protein nature since the inhibitory activity of the trypsinate was destroyed by papain and was not absorbed on a column containing monoclonal antibodies directed against lipoteichoic acid bound to protein A-Sepharose. Binding sites in fibronectin for streptococci and staphylococci, respectively, were localized by analyzing the ability of isolated fragments to inhibit [125I]fibronectin binding to bacteria and by adsorbing 125I-labeled tryptic fragments with staphylococcal and streptococcal cells. Both species of bacteria appeared to preferentially bind a fragment (Mr = approximately 25,000) originating from the N-terminal region of the protein. In addition, streptococci also bound a slightly smaller fragment (Mr = approximately 23,000). Fibronectin receptors solubilized from either streptococci or staphylococci inhibited the binding of fibronectin to both species of bacteria.
在先前的研究中,已表明金黄色葡萄球菌能结合纤连蛋白(P. 库塞拉,《自然》(伦敦)276:718 - 720,1978年),这种相互作用在细菌黏附和调理作用中可能很重要。最近还发现血清学A、C和G组的一些链球菌菌株也能结合纤连蛋白。本文对一株化脓性链球菌的结合特性进行了表征。[125I]纤连蛋白与链球菌细胞的结合类似于与葡萄球菌细胞的结合,且发现其具有时间依赖性、功能不可逆性,并且具有特异性,即除纤连蛋白外的未标记蛋白质不会阻断结合。用蛋白酶处理的细菌基本上失去了结合纤连蛋白的能力,经短暂胰蛋白酶消化从链球菌释放的物质含有活性纤连蛋白受体。该物质抑制了[125I]纤连蛋白与链球菌的结合。抑制活性被吸附在纤连蛋白 - 琼脂糖柱上,但未被未取代的4B琼脂糖柱或卵清蛋白琼脂糖柱吸附。该受体似乎具有蛋白质性质,因为胰蛋白酶消化产物的抑制活性被木瓜蛋白酶破坏,且不被含有针对与蛋白A - 琼脂糖结合的脂磷壁酸的单克隆抗体的柱吸附。通过分析分离片段抑制[125I]纤连蛋白与细菌结合的能力以及用葡萄球菌和链球菌细胞吸附125I标记的胰蛋白酶片段,分别确定了纤连蛋白中与链球菌和葡萄球菌结合的位点。两种细菌似乎都优先结合源自该蛋白质N端区域的一个片段(分子量约为25,000)。此外,链球菌还结合了一个稍小的片段(分子量约为23,000)。从链球菌或葡萄球菌中溶解的纤连蛋白受体抑制了纤连蛋白与这两种细菌的结合。